Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma
Clinical trial NCT01545804 · COMPLETED
Trial details
- NCT number
- NCT01545804
- Sponsor
- National Taiwan University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2016-10-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.